Technological Reverberations To Boost The Orally Disintegrating Tablet Market

1
Orally Disintegrating Tablet Market
Report Id PMRREP14572 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
Technological Reverberations To Boost The Orally
Disintegrating Tablet Market

• Improvements in drug delivery mechanism offering
  quicker onset of action with superior
  bioavailability per dose have transformed
  characteristics of orally administered drugs with
  the development of orally disintegrating tablets
  (ODTs). The global orally disintegrating tablets
  market was valued at nearly US 12 Bn in 2018 and
  will exhibit a solid CAGR during the forecast
  period (2019 2029).
• There has been growing preference among consumers
  and patients for orally disintegrating tablets
  attributed to increasing applications in
  treatment of diseases related to central nervous
  system (CNS), gastrointestinal (GI),
  cardiovascular disorders, and allergy.
• Bayers acquisition of Mercks consumer care unit
  was aimed at gaining shares in ODTs. Claritin, an
  ODT received through this acquisition, was the
  largest revenue generating drug for allergy in
  the U.S. that year.

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/14572
4
Report Inclusions
Persistence Market Research offers a unique
perspective and actionable insights on the Orally
Disintegrating Tablets landscape in its new
study, presenting historical demand assessment
from 2014 2018 and projections from 2019
2029 on the basis of drug class (anti-psychotics,
anti-epileptics, CNS stimulants, anxiolytics,
anti-Parkinsonian drugs, anti-hypertensives,
NSAIDS, anti-allergy drugs, proton pump
inhibitors), disease indication (CNS diseases, GI
diseases, allergy, CVS disorders), distribution
channel (hospital pharmacies, retail pharmacies,
drug stores, online pharmacies), and five key
regions.
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/14572
5
(No Transcript)